With an ejection fraction of 50%, can I still use Cardizem (diltiazem)?

Yes, you can use Cardizem (diltiazem) with an EF of 50%

With an ejection fraction of 50%, diltiazem is appropriate for rate control in atrial fibrillation, as this falls within the preserved ejection fraction range (≥50%) where non-dihydropyridine calcium channel blockers are recommended. 1

Guideline-Based Threshold

The 2024 ESC guidelines explicitly state that diltiazem/verapamil should be used for rate control when LVEF >40% 1. Your patient's EF of 50% clearly exceeds this threshold, placing them in the safe zone for diltiazem use.

The 2023 ACC consensus defines:

• HFpEF (preserved EF): ≥50% - diltiazem appropriate
• HFmrEF (mildly reduced): 40-49% - use with caution
• HFrEF (reduced EF): <40% - avoid diltiazem 2

Your patient at 50% EF is at the lower boundary of preserved function, making diltiazem a guideline-concordant choice.

FDA Label Considerations

The FDA label for Cardizem acknowledges that "worsening of congestive heart failure has been reported in patients with preexisting impairment of ventricular function" 3. However, it also notes that studies in patients with impaired function (EF 24%±6%) showed improvement in ventricular function indices without significant decrease in contractility 3. The label emphasizes caution rather than absolute contraindication, even at lower EFs.

Clinical Evidence Supporting Use at EF 50%

Recent research demonstrates safety at this EF level:

• A 2022 study comparing metoprolol vs diltiazem in HF patients (average EF 48.2%) found no differences in safety outcomes between groups, with 64% having HFpEF 4

• A 2019 study in HFrEF patients showed diltiazem achieved similar rate control with no increase in adverse events compared to metoprolol 5

• A 2018 study found no increased risk of hypotension, ICU transfer, or mortality in low EF patients, though acute kidney injury was slightly higher (10% vs 3.6%) 6

Practical Approach

For your patient with EF 50%:

1. Diltiazem is appropriate - you're above the 40% cutoff
2. Monitor for hypotension - occurs in ~13% of patients 7
3. Watch renal function - check creatinine within 48 hours given the modest AKI risk 6
4. Assess volume status - ensure patient isn't in acute decompensated HF before administration
5. Standard dosing applies - typically 0.25 mg/kg IV push, with additional 0.35 mg/kg if needed 8

Key Caveats

• If your patient has active decompensated heart failure symptoms (pulmonary edema, hypotension, cardiogenic shock), reconsider regardless of EF
• If EF was measured months/years ago, consider repeat assessment as EF can decline
• Beta-blockers remain first-line in HFrEF, but at EF 50%, diltiazem is equally appropriate 1
• Avoid combining with beta-blockers initially due to additive AV nodal effects 3

The 40% threshold is the critical decision point - your patient at 50% EF is safely above this cutoff for diltiazem use.